Results 161 to 170 of about 2,631 (193)
Symptoms of long COVID in children and adolescents: a scoping review. [PDF]
Gusmão ACS, Scaléa ACR, Uehara SCDSA.
europepmc +1 more source
Abstract Objective To evaluate the real‐world effectiveness, safety, and treatment retention of cenobamate (CNB) in patients with drug‐resistant epilepsy (DRE), including ultra‐refractory epilepsy (URE), high seizure burden, and extensive prior treatment history.
Ondřej Strýček +9 more
wiley +1 more source
[Spontaneous bacterial peritonitis in cardiac ascites: A case report and review of the literature]. [PDF]
González Hidalgo V +3 more
europepmc +1 more source
The Roads of Rome for Functional Dyspepsia: From Rome I to Rome V
ABSTRACT Functional dyspepsia (FD) is one of the most common functional gastrointestinal disorders. Its diagnostic, classificatory, and therapeutic concepts have continuously evolved alongside successive iterations of the Rome diagnostic criteria, undergoing profound changes over more than three decades.
Zi‐xing Qian, Wei Wei
wiley +1 more source
Effect of ginger and P6 acupressure on chemotherapy-induced nausea and vomiting: a randomized controlled study. [PDF]
Chenbing X +7 more
europepmc +1 more source
Understanding the Symptom Burden of Complex Skull Base Tumors From the Patient's Perspective
ABSTRACT Background Symptom burden of skull base tumor (SBT) patients, especially those undergoing multimodality treatment, is poorly understood. We aim to understand symptom burden in this patient group using the core module the MD Anderson Symptom Inventory (MDASI).
Shirley Y. Su +8 more
wiley +1 more source
[New therapeutic era for migraine attacks with recently approved monoclonal antibodies, ditans and gepants]. [PDF]
Mínguez-Olaondo A +7 more
europepmc +1 more source
A star in the daylight clinical vignette: Lesional focal epilepsy with cerebral accessory falx
Epileptic Disorders, EarlyView.
Kyle McGrath +3 more
wiley +1 more source
ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source

